We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+22.89%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$357M
AUM Growth
+$3K
Cap. Flow
-$4.39M
Cap. Flow %
-1.23%
Top 10 Hldgs %
47.67%
Holding
68
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$4.39M

Sector Composition

Rank Sector Weight
1 Technology 33.62%
2 Healthcare 24.24%
3 Financials 14.33%
4 Communication Services 7.36%
5 Consumer Discretionary 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
26
Edwards Lifesciences
EW
$47.6B
$5.83M 1.63%
30,900
-61,800
-67% -$4.39M
A icon
27
Agilent Technologies
A
$39.1B
$4.35M 1.22%
60,700
– –
AMT icon
28
American Tower
AMT
$77.7B
$4.22M 1.18%
19,370
– –
DHR icon
29
Danaher
DHR
$135B
$3.87M 1.09%
31,573
– –
VZ icon
30
Verizon
VZ
$194B
$3.73M 1.04%
69,365
– –
TMO icon
31
Thermo Fisher Scientific
TMO
$211B
$3.64M 1.02%
12,839
– –
LULU icon
32
lululemon athletica
LULU
$13B
$3.37M 0.95%
17,800
– –
VAR
33
DELISTED
Varian Medical Systems, Inc.
VAR
$3.03M 0.85%
29,515
– –
MASI
34
DELISTED
Masimo
MASI
$2.6M 0.73%
14,650
– –
ILMN icon
35
Illumina
ILMN
$29.4B
$2.53M 0.71%
9,512
– –
SYK icon
36
Stryker
SYK
$127B
$2.15M 0.6%
12,900
– –
UNH icon
37
UnitedHealth
UNH
$382B
$1.93M 0.54%
7,750
– –
CHD icon
38
Church & Dwight Co
CHD
$23.1B
$1.87M 0.53%
29,200
– –
GIS icon
39
General Mills
GIS
$19.2B
$1.57M 0.44%
29,850
– –
PG icon
40
Procter & Gamble
PG
$343B
$1.31M 0.37%
11,928
– –
AWK icon
41
American Water Works
AWK
$26.3B
$1.06M 0.3%
8,850
– –
NBIX icon
42
Neurocrine Biosciences
NBIX
$17.7B
$1.02M 0.29%
11,750
– –
MAS icon
43
Masco
MAS
$16B
$875K 0.25%
25,300
– –
ATO icon
44
Atmos Energy
ATO
$29.9B
$854K 0.24%
8,610
– –
BFAM icon
45
Bright Horizons
BFAM
$3.99B
$847K 0.24%
8,300
– –
WASH icon
46
Washington Trust Bancorp
WASH
$732M
$806K 0.23%
22,041
– –
HSIC icon
47
Henry Schein
HSIC
$9.74B
$790K 0.22%
15,630
– –
STE icon
48
Steris
STE
$20.9B
$763K 0.21%
5,450
– –
GILD icon
49
Gilead Sciences
GILD
$161B
$689K 0.19%
9,215
– –
IART icon
50
Integra LifeSciences
IART
$1.54B
$643K 0.18%
14,398
– –
1
2
3

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q2 2020 Portfolio in Review

As of Q2 2020, De Burlo Group held 68 positions worth $357M, up 0% from $357M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. De Burlo Group opened no new positions and made no exits, leaving the 68-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • De Burlo Group's biggest Q2 2020 reduction was Edwards Lifesciences, cutting an estimated $4.39M.
  • De Burlo Group's ten largest holdings make up 48% of its $357M portfolio in Q2 2020.
  • De Burlo Group opened 0 new positions and closed 0 in Q2 2020.
  • De Burlo Group's portfolio value rose 0% quarter-over-quarter to $357M.

Based on De Burlo Group's 13F filing for Q2 2020, filed 6 Aug 2020.